ReviewMolecular epidemiology of sporadic breast cancer: The role of polymorphic genes involved in oestrogen biosynthesis and metabolism
Introduction
Breast cancer is the prevailing cancer among women in industrialized countries [1]. Heritable factors are observed in one-fourth of breast cancer cases [2]. However, germline mutations in so-called high-penetrance cancer susceptibility genes, such as BRCA1 and BRCA2, have been shown to account for only up to 5% of all breast cancer cases [3], [4]. Therefore, relatively common genes acting together with endogenous/lifestyle risk factors (low-penetrance genes), are likely to account for a much higher portion of the breast cancer cases together with yet unidentified high-penetrance genes [5].
The molecular mechanisms underlying the development of breast cancer are not completely understood. However, it is generally believed that the initiation of breast cancer is a consequence of cumulative genetic damages leading to genetic alterations that result in activation of proto-oncogenes and inactivation of tumor suppressor genes. These in turn are followed by uncontrolled cellular proliferation and/or aberrant programmed cell death, or apoptosis. Also, the role of reactive oxygen species (ROS) has been related to the aetiology of cancer, as they are known to be mitogenic to variety of cells, and therefore capable of tumor promotion [6].
Most of the risk factors for breast cancer relate to the increased or prolonged exposure to oestrogen. The main effect of oestrogens is thought to be via stimulation of breast-cell proliferation, thereby increasing the chances that a cell bearing a potentially cancer-causing mutation will multiply [7], [8]. The initial genetic damage was previously thought to arise solely from spontaneous mutations or damage triggered by external exposures such as radiation and cigarette smoke. However, current evidence suggests that the metabolic by-products of oestrogen in the body may also act as initiators of cellular alterations [9].
Considerable inter-individual variability has been observed in carcinogen metabolism as well as in the biosynthetic pathways and metabolism of steroid hormones [10]. These person-to-person differences are largely attributed to polymorphism in the genes encoding for the xenobiotic metabolizing enzymes (XMEs). The XME gene polymorphisms may therefore define subpopulations of women with higher lifetime exposure to oestrogens, oestrogen metabolites, and other carcinogens [11]. Such variation could explain a portion of the breast cancer susceptibility associated with reproductive events and hormone exposure, as well as other lifestyle/environmental risk factors. They are therefore considered to account for a high proportion of breast cancer cases.
In this paper, we discuss the potential role of polymorphic genes coding for enzymes involved in oestrogen biosynthesis and metabolism in modulating individual susceptibility to breast cancer.
Section snippets
Descriptive epidemiology of breast cancer
With 1 million new cases diagnosed in the world annually, breast cancer is by far the most common female cancer, comprising about 20% of all new cancers in women [1], [12]. The highest age-adjusted incidence rate is reported for North America, being 86.3 per 100,000 women per year, while the lowest rate, reported in China, is only 11.8 [12]. Breast cancer follows a steeply increasing age gradient up to 50 years of age, after which the rate of increase slows down.
Even though there are three
Oestrogen
All oestrogens have an aromatic A ring, a phenolic hydroxyl group at C-3 and a methyl group at position C-13. Oestradiol (E2) with a hydroxyl group at C-17 and oestrone (E1) with a keto-group at this position, are the major oestrogens in the blood, oestradiol being biologically the most active in breast tissue [102].
Oestrogens and progesterone exert their cellular actions by forming complexes with their respective receptors [103]. The binding efficancy of oestrogen to ER is determined by its
Genetic polymorphisms in oestrogen metabolizing enzymes and breast cancer
Person-to-person differences in the conjugation pathways of both oestrogen and catechol oestrogens may define subpopulations of women with higher lifetime exposure to hormone-dependent growth promotion or to cellular damage from particular oestrogens and oestrogen metabolites. Such variation could explain a portion of the cancer susceptibility associated with reproductive events and hormone exposure. The most widely studied polymorphisms in low-penetrance genes encoding for enzymes with a
Concluding remarks
As discussed in this review, the studies conducted to date on polymorphic estrogen metabolizing enzymes and breast cancer risk have yielded contrasting results. Considerable portion of the differences are anticipated to be due to poor study designs.
Case–control studies are the most commonly used methods to seek potential associations between genetic polymorphisms and the risk of common diseases in the population, and interactions between genetic and environmental risk factors. Many of the
Acknowledgements
This work was supported by the Academy of Finland and the Finnish Konkordia Foundation.
References (278)
Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis
Free Radic. Biol. Med.
(1994)Epidemiology of cancer: global patterns and trends
Toxicol. Lett.
(1998)- et al.
4-Hydroxycatecholestrogen metabolism responses to exercise and training: possible implications for menstrual cycle irregularities and breast cancer
Fertil. Steril.
(1997) - et al.
Hormone replacement therapy and biological aggressiveness of breast cancer
Lancet
(1997) - et al.
Absorption and bioavailability of oestradiol from a gel, a patch and a tablet
Maturitas
(1999) - et al.
Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens
Toxicol. Appl. Pharmacol.
(2000) - et al.
Phenolphthalein metabolite inhibits catechol-O-methyltransferase-mediated metabolism of catechol estrogens: a possible mechanism for carcinogenicity
Toxicol. Appl. Pharmacol.
(2000) - et al.
The antiestrogenic effect of cigarette smoking in women
Am. J. Obstet. Gynecol.
(1990) - et al.
Alcohol-induced breast cancer: a proposed mechanism
Free Radic. Biol. Med.
(1999) - et al.
Etheno DNA–base adducts from endogenous reactive species
Mutat. Res.
(1999)
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium
Am. J. Hum. Genet.
Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism
Mutat. Res.
ABC of breast diseases, breast cancer-epidemiology, risk factors, and genetics
BMJ
Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland
N. Engl. J. Med.
Inherited susceptibility to breast cancer
Cancer Surv.
Tumor suppressor genes in breast cancer
Endocr. Relat. Cancer
Ongoing research to identify environmental risk factors in breast carcinoma
Cancer
Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis
Proc. Natl. Acad. Sci. U.S.A.
Tissue-specific synthesis and oxidative metabolism of estrogens
J. Natl. Cancer Inst. Monogr.
Endogenous estrogens as carcinogens through metabolic activation (in process citation)
J. Natl. Cancer Inst. Monogr.
A systematic review of genetic polymorphisms and breast cancer risk
Cancer Epidemiol. Biomarkers Prev.
Hormonal carcinogenesis
Carcinogenesis
Global breast cancer mortality statistics
CA Cancer J. Clin.
Serum sex hormone levels are related to breast cancer risk in postmenopausal women
Environ. Health Perspect.
Serum oestradiol and breast cancer risk
Endocr. Relat. Cancer
A prospective study of estradiol and breast cancer in Japanese women
Cancer Epidemiol. Biomarkers Prev.
Endogenous hormones and breast cancer risk
Epidemiol. Rev.
Estrogens and breast cancer
Carcinogenesis
Adolescence and breast carcinoma risk
Cancer
Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood
Int. J. Cancer
Physical exercise and reduced risk of breast cancer in young women
J. Natl. Cancer Inst.
Reproductive factors and breast cancer
Epidemiol. Rev.
Do regular ovulatory cycles increase breast cancer risk?
Cancer
Age at any full-term pregnancy and breast cancer risk
Am. J. Epidemiol.
Breast carcinoma etiology: current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations
Cancer
Developmental, cellular, and molecular basis of human breast cancer (in process citation)
J. Natl. Cancer Inst. Monogr.
History of breast-feeding in relation to breast cancer risk: a review of the epidemiologic literature
J. Natl. Cancer Inst.
Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status
Am. J. Epidemiol.
Body size, physical activity, and breast cancer hormone receptor status: results from two case–control studies (in process citation)
Cancer Epidemiol. Biomarkers Prev.
Diet, body size, and breast cancer
Epidemiol. Rev.
Aromatase within the breast
Endocr. Relat. Cancer
Anthropometry and breast cancer. Body size—a moving target
Cancer
Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status
Int. J. Cancer
Body size and breast cancer risk in black women and white women: the Carolina Breast Cancer Study
Am. J. Epidemiol.
Estrogen–progestin replacement and risk of breast cancer
JAMA
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial
JAMA
Effect of hormone replacement therapy on the pathological stage of breast cancer: population based, cross sectional study
BMJ
Postmenopausal hormone therapy and mortality
N. Engl. J. Med.
Cited by (232)
Sequence variants in FSHR and CYP19A1 genes and the ovarian response to controlled ovarian stimulation
2019, Fertility and SterilityCitation Excerpt :A c.*19C>T single nucleotide variant located in the 3ʹ-UTR of the CYP19A1 gene (rs10046) has been related to levels of circulating E2 and to the estradiol/testosterone ratio (37, 38). Several studies have linked this variant with breast cancer risk (39). Sequence variants in linkage disequilibrium with rs10046, as in the case of a tetranucleotide repeat variants (TTTA)n in intron 4, have also been reported to affect ovarian aromatase activity and to be associated with breast cancer survival (40–42).
Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor immunity
2015, Life SciencesCitation Excerpt :Leptin and estradiol both stimulated the proliferation of ZR-75-1 cells and this effect was amplified with a combined treatment of leptin and estradiol [23]. In the estrogen-dependent cell lines MCF-7 and MDA-MB-361 [116], leptin did not alter the expression of aromatase but increased that of CYP1B1 known for its involvement in the oxidative metabolism of estrogens (hydroxylation) and the activation of exogenous carcinogens [74,96,97]. However, some studies found that leptin was able to stimulate ER and aromatase gene expression in MCF-7 cells [81,89].
Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies
2022, Frontiers in Oncology